반응식
[OH:1][C:2]1[CH:3]=[CH:4][CH:5]=[C:6]2[C:11]=1[CH:10]=[C:9]([S:12]([OH:15])(=[O:14])=[O:13])[CH:8]=[CH:7]2.[OH-].[K+].Cl[CH2:19][CH2:20][CH2:21][N:22]1[CH2:27][CH2:26][O:25][CH2:24][CH2:23]1.[Na+].[I-]>CN(C=O)C.CCCC[N+](CCCC)(CCCC)CCCC.[I-].O>[O:25]1[CH2:26][CH2:27][N:22]([CH2:21][CH2:20][CH2:19][O:1][C:2]2[CH:3]=[CH:4][CH:5]=[C:6]3[C:11]=2[CH:10]=[C:9]([S:12]([OH:15])(=[O:13])=[O:14])[CH:8]=[CH:7]3)[CH2:23][CH2:24]1참가 물질
반응물 4
생성물 1
시약·촉매·용매 3
반응 조건
- 온도
- 60 °C
실험 절차
To a solution of 8-hydroxynaphthalene-2-sulfonic acid (Intermediate 26A, 300 mg, 1.34 mmol) and pulverized KOH (300 mg, 5.35 mmol) in DMF (2.0 mL) was added 4-(3-chloropropyl)morpholine (438 mg, 2.68 mmol) and NaI (401 mg, 2.68 mmol). The resulting reaction mixture was stirred at 60° C. for 12 h. TBAI (494 mg, 1.34 mmol) was then added followed by 4-(3-chloropropyl)morpholine (438 mg, 2.68 mmol). The reaction mixture was stirred at 60° C. for an additional 12 h, then diluted with water and filtered. The filtrate was purified directly using preparative HPLC to give the title compound (150 mg, 29%). 1H NMR (DMSO-d6) δ 8.49-8.34 (m, 1H), 7.80-7.70 (m, 1H), 7.70-7.60 (m, 1H), 7.36-7.19 (m, 2H), 6.89-6.77 (1 H, m), 3.95 (br s, 2H), 3.65 (br s, 4H), 3.48-3.32 (m, 2H), 3.26-3.06 (m, 2H), 2.57-2.44 (m, 2H), 2.37-2.13 (m, 2H); MS(ESI−) m/z 350.4 (M−H)−.
후처리
- customThe resulting reaction mixture
- stirringThe reaction mixture was stirred at 60° C. for an additional 12 h
- filtrationfiltered
- customThe filtrate was purified directly
출처 및 근거
- ORD 기록
- ord-cbc1b18ba2834797ad18fc97e4776306
- 출처 데이터셋
- uspto-grants-2016_05
- 특허 번호
- US09346795B2
연결된 노트
불러오는 중…